Prawo i regulacje · 19/11/2007

DEA Finalizes Rule to Allow Multiple Prescriptions for Schedule II Controlled Substances

The Drug Enforcement Administration (DEA) is finalizing a rule change that would allow healthcare practitioners to provide patients with multiple prescriptions for the same Schedule II controlled substance, with the combined effect of up to a 90-day supply, as proposed in a 2006 Notice of Proposed Rulemaking.